# Substance abuse treatment center software built around the authorization clock and 42 CFR Part 2

> A substance abuse treatment center is a licensed facility that delivers substance use disorder care at a defined level of intensity, from 1.0 outpatient counselling through 3.5 residential to 3.7 medically monitored inpatient. Its records sit under 42 CFR Part 2, which is stricter than HIPAA and whose alignment rule carried a compliance date of February 16, 2026. Neurobird holds the census, the authorization countdown and the Part 2 consent in one place.

- URL: https://neurobird.com/treatmentctr/
- Product: Neurobird Substance Abuse Treatment Center Operations Platform
- Niche: substance abuse treatment center
- Buyer: substance use treatment centers
- Status: in development, open for early access
- Updated: 2026-08-21

## What Neurobird Substance Abuse Treatment Center does

- Admit against a level of care and a payer authorization, not just a bed number
- Count down treatment plan reviews, authorization end dates and required contacts on one board
- Scope, date and log every Part 2 disclosure so consent is provable rather than assumed
- Show the state, the payer and the accreditor the same documentation without three rebuilds

## How it works

1. **Admit against a level of care** ASAM level, licence type and payer authorization are captured at admission, so the census always knows what each bed is approved for.
2. **Watch the clocks, not the calendar** Treatment plan reviews, authorization end dates and required contacts count down on one board, each with a named owner.
3. **Release records the Part 2 way** Consent is scoped, dated and revocable, and every disclosure is logged, because Part 2 asks more of you than HIPAA does.

## From the source material

> Diminished control is a core defining concept of psychoactive substance dependence or addiction.

Source: pmc.ncbi.nlm.nih.gov, https://pmc.ncbi.nlm.nih.gov/articles/PMC3164585/

## Industry context

- **2026** February 16, 2026 was the compliance date for the final rule aligning 42 CFR Part 2 with HIPAA, changing how consent, redisclosure and enforcement work for every program holding Part 2 records. (source: Federal Register, confidentiality of substance use disorder patient records, https://www.federalregister.gov/documents/2024/02/16/2024-02544/confidentiality-of-substance-use-disorder-patient-records)
- **2.31** The section listing what a valid Part 2 consent must contain. A consent missing an element is not a consent, and the disclosure made under it is a violation rather than a filing error. (source: eCFR, 42 CFR 2.31, https://www.ecfr.gov/current/title-42/section-2.31)
- **8.12** Federal opioid treatment program standards covering accreditation, medical direction, staffing, dosing and documentation for programs dispensing methadone or buprenorphine. (source: eCFR, 42 CFR 8.12, https://www.ecfr.gov/current/title-42/section-8.12)
- **50 states** Medicaid is the largest payer for substance use disorder treatment, and each state layers its own covered services, documentation and authorization rules on top of the federal floor. (source: Medicaid.gov, behavioral health services, https://www.medicaid.gov/medicaid/benefits/behavioral-health-services/index.html)
- **1 directory** The federal treatment locator is where a large share of self referrals begin, so your licence type, levels of care and accepted payment have to be as correct there as in your chart system. (source: SAMHSA, findtreatment.gov, https://findtreatment.gov/)

## Pricing

- Single program: $190 per program, per month
- Multi level: $420 per program, per month
- Multi site: $720 per program, per month

## Questions

### What is 42 CFR Part 2 and how is it different from HIPAA?

42 CFR Part 2 is the federal confidentiality rule for substance use disorder patient records. It is stricter than HIPAA: it restricts redisclosure, it attaches to the program rather than only to the record, and consent has to meet specific content requirements in section 2.31. The final rule aligning Part 2 with HIPAA carried a compliance date of February 16, 2026.

### What are ASAM levels of care?

A common framework for describing treatment intensity, running from 1.0 outpatient through 2.1 intensive outpatient, 3.5 clinically managed high intensity residential and up to 3.7 medically monitored inpatient. Your licence, your staffing ratios and your payer authorizations are all written against the level, so recording it precisely is not clinical decoration.

### Why do authorizations lapse?

Because the review date sits in a payer portal and the clinical work sits in the chart. A 30 day residential stay authorized 7 days at a time needs 4 successful concurrent reviews, and the one that gets missed is usually the one nobody owned.

### Is this an electronic health record?

No, and it is not trying to replace one. It holds the operational layer most centers keep on whiteboards and spreadsheets: census by level of care, authorization countdowns, documentation due dates and Part 2 consent status.

### Does early access mean we can use it today?

No. Early access means you see the working preview, you shape what ships first, and you get early access pricing when it does. There is no login yet and we will not pretend otherwise.

## Sources

- [eCFR, 42 CFR Part 2](https://www.ecfr.gov/current/title-42/chapter-I/subchapter-A/part-2)
- [Federal Register, Part 2 final rule](https://www.federalregister.gov/documents/2024/02/16/2024-02544/confidentiality-of-substance-use-disorder-patient-records)
- [eCFR, 42 CFR 8.12 opioid treatment program standards](https://www.ecfr.gov/current/title-42/section-8.12)
- [Medicaid.gov, behavioral health services](https://www.medicaid.gov/medicaid/benefits/behavioral-health-services/index.html)

## Contact

- office@neurobird.com
- https://neurobird.com/